Fig. 1: The response rates of patients in the EPAG+tacrolimus group and EPAG monotherapy group. | Blood Cancer Journal

Fig. 1: The response rates of patients in the EPAG+tacrolimus group and EPAG monotherapy group.

From: Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial

Fig. 1: The response rates of patients in the EPAG+tacrolimus group and EPAG monotherapy group.The alternative text for this image may have been generated using AI.

The ORR to EPAG+tacrolimus was significantly higher than that to EPAG monotherapy at the 6th month/last follow-up. CR complete response, EPAG eltrombopag, PR partial response, ORR overall response. *P < 0.05, **P < 0.01.

Back to article page